KNK437, a benzylidene lactam compound, sensitises prostate cancer cells to the apoptotic effect of hyperthermia
/in Hyperthermia, International Publications, Prostate Cancer /von 2011-01-04 / Int J Hyperthermia 2011;27(1):63-73[Study on the specific immunity induced by dendritic cell vaccine loading allogenic microvascular endothelial cell bEnd.3 antigen against U14 cervical cancer cell in mice]
/in Cervical Cancer, Dendritic Cells, International Publications /von 2011-01-01 / Zhonghua Fu Chan Ke Za Zhi 2011 Jan;46(1):52-7New perspectives in glioma immunotherapy
/in Dendritic Cells, Glioblastoma, International Publications /von 2011-01-01 / Curr. Pharm. Des. 2011;17(23):2439-67Inhibition of B16 murine melanoma metastasis and enhancement of immunity by fever-range whole body hyperthermia
/in Hyperthermia, International Publications /von 2011-01-01 / Int J Hyperthermia 2011;27(3):275-85Sipuleucel-T: in metastatic castration-resistant prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-01-01 / Drugs 2011 Jan;71(1):101-8Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2011-01-01 / J. Immunother. 2011 Jan;34(1):100-6Immunotherapy as a strategy for the treatment of non-small-cell lung cancer
/in International Publications, NSCLC /von 2011-01-01 / Therapy 2011 Jan;8(1):43-54Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy
/in Dendritic Cells, International Publications /von 2010-12-20 / Clin. Dev. Immunol. 2010;2010:565643Antitumor vaccination by Newcastle Disease Virus Hemagglutinin-Neuraminidase plasmid DNA application: changes in tumor microenvironment and activation of innate anti-tumor immunity
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2010-12-18 / Vaccine 2011 Feb;29(6):1185-93
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de